Dr. Kamran Ali Ahmed, MD

Dr. Ahmed practices at Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center.

Dr. Ahmed's NPI, 1659633915, was assigned on June 13, 2012. Dr. Ahmed graduated from Mayo Clinic Alix School of Medicine - Rochester in 2012. Dr. Ahmed holds Florida license TRN19256.

Dr. Ahmed's primary practice is Moffitt Cancer Hospital, at 12902 Magnolia Dr, Tampa, FL 33612.

Dr. Ahmed's primary practice is Moffitt Cancer Hospital in Tampa, Florida, part of Moffitt Cancer Center. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Ahmed to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ahmed practices, 2 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Ahmed's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Ahmed is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Ahmed's licenses on file in 2 states: Florida and Texas.

Dmand AI lists bone cancer radiation, brain cancer radiation, breast cancer radiation and cervical cancer radiation among the conditions Dr. Ahmed treats.

CMS data shows 1,003 Medicare services from Dr. Ahmed across 6 procedure codes in 2024, for 318 Medicare patients. Medicare paid $42,504 for them.

CMS counts 318 Medicare patients who saw Dr. Ahmed in 2024. The largest group is 65 to 74, with 166 patients. 75% of them have cancer, and 75% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ahmed's median patient age at 66, with 64% women.

In 2024, Dr. Ahmed wrote 29 Medicare Part D claims for 21 patients. 83% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $280 in total drug cost. In 2021, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Ahmed for performance year 2024, reported as part of a group. Dr. Ahmed accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ahmed as offering telehealth.

Dmand AI links 336 papers to Dr. Ahmed, published from 2006 to 2025. 2021 was the busiest year, with 25. The most frequent topics are Clinical Competence, Urology and Simulation Training. Dr. Ahmed has published most often in BJU Int. Dr. Ahmed's most frequent co-authors are Kamran Ahmed, MD, Arnold Besohong Etame, MD and Peter A. Forsyth, MD.

Dmand AI links Dr. Ahmed to 7 clinical trials, 3 of them phase 1/2 studies. 6 are still active or recruiting. Conditions studied include Brain Neoplasms, Triple Negative Breast Neoplasms and Breast Neoplasms. H. Lee Moffitt Cancer Center and Research Institute sponsors the most, 6.

CMS Open Payments shows 14 general payments to Dr. Ahmed from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Medtronic, Inc. paid the most, $350.

Dr. Ahmed graduated from Mayo Clinic Alix School of Medicine - Rochester in 2012. Dr. Ahmed is a member of ASTRO and ASCO.

Dr. Ahmed is in network with 9 carriers, including Excellus BlueCross BlueShield, United Healthcare and Humana. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.